Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Jacob

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|January 9, 2007
Regulation of the gating of BKCa channel by lipid bilayer thicknessChunbo Yuan, Robert J O'Connell, Robert F Jacob, et al.
Journal of Cardiovascular Pharmacology|August 31, 2012
Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive ratsR Preston Mason, Robert F Jacob, Ruslan Kubant, et al.
Journal of Cardiovascular Pharmacology|August 8, 2006
Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activityR Preston Mason, Ruslan Kubant, Robert F Jacob, et al.
BMC Pharmacology & Toxicology|October 1, 2013
The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cellsR Preston Mason, Robert F Jacob, J Jose Corbalan, et al.
Investigative Ophthalmology & Visual Science|October 17, 2013
1,2-naphthoquinone stimulates lipid peroxidation and cholesterol domain formation in model membranesRobert F Jacob, Michael D Aleo, Yehudi Self-Medlin, et al.
Atherosclerosis|November 9, 2004
Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDsMary F Walter, Robert F Jacob, Charles A Day, et al.
British Journal of Clinical Pharmacology|January 31, 2012
Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variantsR Preston Mason, Robert F Jacob, Ruslan Kubant, et al.
Journal of Cardiovascular Pharmacology|February 22, 2008
Effect of beta-blockers on endothelial function during biological aging: a nanotechnological approachPhilip Funovic, Mykhaylo Korda, Ruslan Kubant, et al.
Journal of the American College of Cardiology|March 22, 2008
Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT studyMary F Walter, Robert F Jacob, Rebekah E Bjork, et al.
Journal of Atherosclerosis and Thrombosis|June 15, 2011
Effect of enhanced glycemic control with saxagliptin on endothelial nitric oxide release and CD40 levels in obese ratsR Preston Mason, Robert F Jacob, Ruslan Kubant, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|January 9, 2007
Regulation of the gating of BKCa channel by lipid bilayer thicknessChunbo Yuan, Robert J O'Connell, Robert F Jacob, et al.
Journal of Cardiovascular Pharmacology|August 31, 2012
Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive ratsR Preston Mason, Robert F Jacob, Ruslan Kubant, et al.
Journal of Cardiovascular Pharmacology|August 8, 2006
Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activityR Preston Mason, Ruslan Kubant, Robert F Jacob, et al.
BMC Pharmacology & Toxicology|October 1, 2013
The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cellsR Preston Mason, Robert F Jacob, J Jose Corbalan, et al.
Investigative Ophthalmology & Visual Science|October 17, 2013
1,2-naphthoquinone stimulates lipid peroxidation and cholesterol domain formation in model membranesRobert F Jacob, Michael D Aleo, Yehudi Self-Medlin, et al.
Atherosclerosis|November 9, 2004
Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDsMary F Walter, Robert F Jacob, Charles A Day, et al.
British Journal of Clinical Pharmacology|January 31, 2012
Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variantsR Preston Mason, Robert F Jacob, Ruslan Kubant, et al.
Journal of Cardiovascular Pharmacology|February 22, 2008
Effect of beta-blockers on endothelial function during biological aging: a nanotechnological approachPhilip Funovic, Mykhaylo Korda, Ruslan Kubant, et al.
Journal of the American College of Cardiology|March 22, 2008
Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT studyMary F Walter, Robert F Jacob, Rebekah E Bjork, et al.
Journal of Atherosclerosis and Thrombosis|June 15, 2011
Effect of enhanced glycemic control with saxagliptin on endothelial nitric oxide release and CD40 levels in obese ratsR Preston Mason, Robert F Jacob, Ruslan Kubant, et al.
Pageof 4